Zdrowie i gospodarka · 27/06/2019

FDA Releases Draft Guidance on Optimizing Safety Data Collection for Late-Stage Drug Studies

The FDA has made available a draft guidance from the International Council for Harmonisation (ICH) that recommends a selective approach to safety data collection in late-stage drug studies, aiming to advance clinical research and reduce patient burden.